Atypical Chondroid Syringoma of the Toe Radiopathologic Correlation
被引:0
|
作者:
Ge, Connie
论文数: 0引用数: 0
h-index: 0
机构:
Univ Massachusetts, Chan Med Sch, Worcester, MA, Brazil
Univ Massachusetts, Chan Med Sch, 55 N Lake Ave, Worcester, MA 01605 USAUniv Massachusetts, Chan Med Sch, Worcester, MA, Brazil
Ge, Connie
[1
,3
]
Gu, Joey
论文数: 0引用数: 0
h-index: 0
机构:
Warren Alpert Med Sch, Providence, RI USAUniv Massachusetts, Chan Med Sch, Worcester, MA, Brazil
Gu, Joey
[2
]
Deng, April
论文数: 0引用数: 0
h-index: 0
机构:
Univ Massachusetts, Chan Med Sch, Worcester, MA, BrazilUniv Massachusetts, Chan Med Sch, Worcester, MA, Brazil
Deng, April
[1
]
Joshi, Ganesh
论文数: 0引用数: 0
h-index: 0
机构:
Univ Massachusetts, Chan Med Sch, Worcester, MA, BrazilUniv Massachusetts, Chan Med Sch, Worcester, MA, Brazil
Joshi, Ganesh
[1
]
Most, Mathew
论文数: 0引用数: 0
h-index: 0
机构:
Univ Massachusetts, Chan Med Sch, Worcester, MA, BrazilUniv Massachusetts, Chan Med Sch, Worcester, MA, Brazil
Most, Mathew
[1
]
Tai, Ryan
论文数: 0引用数: 0
h-index: 0
机构:
Univ Massachusetts, Chan Med Sch, Worcester, MA, BrazilUniv Massachusetts, Chan Med Sch, Worcester, MA, Brazil
Tai, Ryan
[1
]
机构:
[1] Univ Massachusetts, Chan Med Sch, Worcester, MA, Brazil
[2] Warren Alpert Med Sch, Providence, RI USA
[3] Univ Massachusetts, Chan Med Sch, 55 N Lake Ave, Worcester, MA 01605 USA
Although chondroid syringoma rarely occurs outside the head and neck, the majority of malignant chondroid syringomas are identified in the extremities. Here, we present a case of atypical chondroid syringoma in the fifth toe. Diagnosis of chondroid syringoma with atypical cells was made following initial excisional biopsy and histology, necessitating repeated surgery for positive margins. In this case report, we examine the radiopathologic correlation of this diagnosis, detail the imaging findings of benign and malignant chondroid syringomas, and highlight how magnetic resonance imaging can be used to guide surgical planning and treatment course of this potentially malignant tumor. (J Am Podiatr Med Assoc 113(3), 2023)